The possible role of factor H in complement activation-related pseudoallergy (CARPA): A failed attempt to correlate blood levels of FH with liposome-induced hypersensitivity reactions in patients with autoimmune disease

European Journal of Nanomedicine

Volumn 7, Issue 1, 2015, Pages 7-14

  Fülöp, Tamas Gyula ^a,b   Józsi, Mihály ^c   Metselaar, Josbert ^b,d   Storm, Gert ^b,e   Rosivall, Laszló ^a   Szebeni, Janos ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

chronic inflammatory disease; complement; FHR; hypersensitivity reactions; liposomes

Indexed keywords

BLOOD; CHEMICAL ACTIVATION; DISEASES; LIPOSOMES; PROTEINS;

AUTOIMMUNE DISEASE; CHRONIC INFLAMMATORY DISEASE; COMPLEMENT; COMPLEMENT ACTIVATIONS; FHR; HYPERSENSITIVITY REACTION; INFLAMMATORY BOWEL DISEASE; RHEUMATOID ARTHRITIS;

PATIENT TREATMENT;

COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN; CONTRAST MEDIUM; LIPOSOME; PREDNISOLONE SODIUM PHOSPHATE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ALLERGY; AUTOIMMUNE DISEASE; CLINICAL OBSERVATION; CLINICAL TRIAL (TOPIC); COMPLEMENT ACTIVATION; COMPLEMENT ACTIVATION RELATED PSEUDOALLERGY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATORY BOWEL DISEASE; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS;

EID: 84924916651     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.1515/ejnm-2015-0004     Document Type: Review

References (21)

1. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010;11:785-97.
2. Thurman JM, Holers VM. The central role of the alternative complement pathway in human disease. J Immunol 2006;176:1305-10.
3. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009:9:729-40.
4. Kopp A, Hebecker M, Svobodová E, Józsi M. Factor H: a complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules 2012:2:46-75.
5. Makou E, Herbert AP, Barlow PN. Functional anatomy of complement factor H. Biochemistry 2013;52:3949-62.
6. Blaum BS, Hannan JP, Herbert AP, Kavanagh D, Uhrín D, Stehle T. Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat Chem Biol 2015:11:77-82.
7. Józsi M, Meri S. Factor H-related proteins. Methods Mol Biol 2014:1100:225-36.
8. Goicoechea de Jorge E, Caesar J, Malik TH, Patel M, Colledge M, Johnson S, et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc Natl Acad Sci USA 2013:110:4685-90.
9. Tortajada A, Yébenes H, Abarrategui-Garrido C, Anter J, García-Fernández JM, Martínez-Barricarte R, et al. C3 glomerulopathyassociated CFHR1 mutation alters FHR oligomerization and complement regulation. J Clin Invest 2013:123:2434-46.
10. Chen Q, Wiesener M, Eberhardt HU, Hartmann A, Uzonyi B, Kirschfink M, et al. Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J Clin Invest 2014:124:45-55.
11. Ferreira VP, Pangburn M, Cortés C. Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 2010:47:2187-97.
12. Sculier JP, Coune A, Brassinne C, Laduron C, Atassi G, Ruysschaert JM, et al. Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data. J Clin Oncol 1986;4:789-97.
13. Boyajyan A, Ghazaryan H, Stepanyan A, Zakharyan R. Genetic polymorphisms of complement factor H in schizophrenia and ischemic stroke. Mol Immunol 2013;56:294.
14. Lieberman P, Siegle R, Treadwell G. Radiocontrast reactions. Clin Rev Allergy 1986:4:229-45.
15. Lieberman P. Anaphylactoid reactions to radiocontrast materia. Clin Rev Allergy 1991;9:319-38.
16. Szebeni J. Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs and radiocontrast agents. Crit Rev Ther Drug Carr Syst 2001;18:567-606.
17. Szebeni J. Hypersensitivity reactions to radiocontrast media: the role of complement activation. Curr Allergy Asthma Rep 2004;4:25-30.
18. Szebeni J, Kádas J, Lázár J, Takács L, Kurucz I. Plasma proteome profiling with monoclonal antibody libraries: a pilot biomarker analysis for nanomedicine-induced complement activation. Adv Nanopart 2013;2:133-44.
19. Kuznetsova NR, Vodovozova EL. Differential binding of plasma proteins by liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the bilayer. Russian in Biokhimiya 2014;79:797-804.
20. De Paula PF, Barbosa JE, Junior PR, Ferriani, VP, Latorre MR, Nudelman V, et al. Ontogeny of complement regulatory proteins-concentrations of factor H, factor I, C4b-binding protein, properdin and vitronectin in healthy children of different ages and in adults. Scand J Immunol 2003;58:572-7.
21. Hakobyan S, Harris CL, Tortajada A, Goicochea de Jorge E, García-Layana A. Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: Application to assessing risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49:1983-90.